Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-007982)

Filing Details

Accession Number:: 0001209191-10-007982
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-02-09 12:00:00
Reporting Period:: 2010-02-05

Filing Date:: 2010-02-09
Accepted Time:: 2010-02-09 19:24:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1346901	Jeffrey Raser	Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130	Senior Vp, Sales And Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-02-05	50,000	$1.20	50,000	No	4	M	Direct
Common Stock	Disposition	2010-02-05	57,500	$3.03	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2010-02-05	50,000	$0.00	50,000	$1.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-06-27	No	4	M	Direct

Footnotes

This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Of the 57,500 shares sold, 50,000 shares were obtained upon the exercise of stock options.
50,000 shares of common stock subject to the option are vested and exercisable as of 2/5/2010.
Not applicable.